Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 9568, October 1, 2007. doi: 10.1158/0008-5472.CAN-06-2707
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchiya, N.
Right arrow Articles by Nakagama, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, N.
Right arrow Articles by Nakagama, H.

Clinical Research

SND1, a Component of RNA-Induced Silencing Complex, Is Up-regulated in Human Colon Cancers and Implicated in Early Stage Colon Carcinogenesis

Naoto Tsuchiya, Masako Ochiai, Katsuhiko Nakashima, Tsuneyuki Ubagai, Takashi Sugimura and Hitoshi Nakagama

Biochemistry Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

Requests for reprints: Hitoshi Nakagama, Biochemistry Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Phone: 81-3-3547-5239; Fax: 81-3-3542-2530; E-mail: hnakagam{at}gan2.res.ncc.go.jp.

Colon cancers have been shown to develop after accumulation of multiple genetic and epigenetic alterations with changes in global gene expression profiles, contributing to the establishment of widely diverse phenotypes. Transcriptional and posttranscriptional regulation of gene expression by small RNA species, such as the small interfering RNA and microRNA and the RNA-induced silencing complex (RISC), is currently drawing major interest with regard to cancer development. SND1, also called Tudor-SN and p100 and recently reported to be a component of RISC, is among the list of highly expressed genes in human colon cancers. In the present study, we showed remarkable up-regulation of SND1 mRNA in human colon cancer tissues, even in early-stage lesions, and also in colon cancer cell lines. When mouse Snd1 was stably overexpressed in IEC6 rat intestinal epithelial cells, contact inhibition was lost and cell growth was promoted, even after the cells became confluent. Intriguingly, IEC6 cells with high levels of Snd1 also showed an altered distribution of E-cadherin from the cell membrane to the cytoplasm, suggesting loss of cellular polarity. Furthermore, the adenomatous polyposis coli (Apc) protein was coincidentally down-regulated, with no significant changes in the Apc mRNA level. Immunohistochemical analysis using chemically induced colonic lesions developed in rats revealed overexpression of Snd1 not only in colon cancers but also in aberrant crypt foci, putative precancerous lesions of the colon. Up-regulation of SND1 may thus occur at a very early stage in colon carcinogenesis and contribute to the posttranscriptional regulation of key players in colon cancer development, including APC and ß-catenin. [Cancer Res 2007;67(19):9568–76]




This article has been cited by other articles:


Home page
Cancer Genomics ProteomicsHome page
N. VALERI, C. M. CROCE, and M. FABBRI
Pathogenetic and Clinical Relevance of MicroRNAs in Colorectal Cancer
Cancer Genomics Proteomics, July 1, 2009; 6(4): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Kuruma, Y. Kamata, H. Takahashi, K. Igarashi, T. Kimura, K. Miki, J. Miki, H. Sasaki, N. Hayashi, and S. Egawa
Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer
Am. J. Pathol., June 1, 2009; 174(6): 2044 - 2050.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. K. Starr, R. Allaei, K. A. T. Silverstein, R. A. Staggs, A. L. Sarver, T. L. Bergemann, M. Gupta, M. G. O'Sullivan, I. Matise, A. J. Dupuy, et al.
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer
Science, March 27, 2009; 323(5922): 1747 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. S. Lee, K. E. Latham, and C. A. VandeVoort
Effects of in vitro maturation on gene expression in rhesus monkey oocytes
Physiol Genomics, October 8, 2008; 35(2): 145 - 158.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Paukku, N. Kalkkinen, O. Silvennoinen, K. K. Kontula, and J. Y. A. Lehtonen
p100 increases AT1R expression through interaction with AT1R 3'-UTR
Nucleic Acids Res., August 1, 2008; 36(13): 4474 - 4487.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C.-L. Li, W.-Z. Yang, Y.-P. Chen, and H. S. Yuan
Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing
Nucleic Acids Res., June 1, 2008; 36(11): 3579 - 3589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.